[{"Assets_0_Q2_USD":49784000.0,"CommonStockSharesOutstanding_0_Q2_shares":48324000.0,"EarningsPerShareBasic_1_Q2_USD":-0.13,"EarningsPerShareBasic_2_Q2_USD":-0.31,"EarningsPerShareDiluted_1_Q2_USD":-0.13,"EarningsPerShareDiluted_2_Q2_USD":-0.31,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-11558000.0,"NetIncomeLoss_1_Q2_USD":-6280000.0,"NetIncomeLoss_2_Q2_USD":-13740000.0,"StockholdersEquity_0_Q2_USD":30637000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":47232000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":44258000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":47232000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":44258000.0,"Ticker":"CDXS","CIK":"1200375","name":"CODEXIS INC","OfficialName":"Codexis Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1143569916.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20170809"}]